PBB geneid 3643 In molecular biology , the insulinreceptor is a transmembrane receptor transmembrane receptor proteomics receptor that is activated by insulin . ref name pmid19274663 cite journal author Ward CW, Lawrence MC title Ligand induced activation of the insulinreceptor a multi step process ... the insulinreceptor . The beta subunits pass through the cellular membrane and are linked by disulfide bond s. The alpha and beta subunits are encoded by a single gene gene INSR . The insulinreceptor ... Receptor include a protein called IRS 1 for insulinreceptor substrate 1 . IRS 1 binding and phosphorylation ... receptor is inducing glucose uptake. For this reason insulin insensitivity , or a decrease in insulinreceptor signaling, leads to diabetes mellitus type 2 the cells are unable to take up ... or Leprechaunism. This autosomal recessive disorder results in a totally non functional insulinreceptor ... synthesis Glycogen synthesis is also stimulated by the insulinreceptor via IRS 1. In this case ... receptor complex followed by the action of insulin degrading enzyme . Most insulin molecules ... Insulinreceptor has been shown to Protein protein interaction interact with Ectonucleotide ... PC 1 inhibition of insulinreceptor function occurs via direct interaction with the receptor ... M, Hinoda Y, Kikkawa R, Yachi A, Shigeta Y, Kashiwagi A year 1994 month Mar. title Insulinreceptor ... of protein tyrosine phosphatase 1D in insulinreceptorinsulinreceptor substrate 1 interaction ... protein that binds to the insulinreceptor and inhibits its function journal PNAS Proc. Natl ... J M, Gustafson T A year 1998 month Mar. title Grb10 interacts differentially with the insulinreceptor, insulin like growth factor I receptor, and epidermal growth factor receptor via the Grb10 Src ... Jan. title Human GRB IRbeta GRB10. Splice variants of an insulin and growth factor receptor binding ... Evidence for an interaction between the insulinreceptor and Grb7. A role for two of its binding domains ... more details
Insulinreceptor substrate IRS is an important ligand in the insulin response of human cells. IRS 1 , for example, is an IRS protein which contains a phosphotyrosine binding domain PTB domain . In addition, the insulinreceptor contains a NPXpY protein domain domain . The PTB domain binds the NPXpY domain. Thus, the insulinreceptor binds IRS. Genes Gene IRS1 see also Insulinreceptor substrate 1 Gene IRS2 see also IRS2 Insulinreceptor substrate 2 Gene IRS3L Gene IRS4 References cite journal author van der Geer P, Wiley S, Pawson T title Re engineering the target specificity of the insulinreceptor by modification of a PTB domain binding site journal Oncogene volume 18 issue 20 pages 3071 5 year 1999 pmid 10340378 doi 10.1038 sj.onc.1202879 Category Coordination chemistry Category Chemical bonding ... more details
PBB geneid 3480 The Insulin like Growth Factor 1 IGF 1 Receptor is a transmembrane receptor transmembrane ... 320 kDa. The receptor is a member of a family which consists of the InsulinReceptor and the Insulin ... IGF 1R and the insulinreceptor. In response to ligand binding, the chains induce the tyrosine ... C, Hofmann F, Krystal GW title The insulin like growth factor I receptor kinase inhibitor, NVP ADW742 ... D, Knowlden JM, Williams S, Wakeling AE, Nicholson RI title Insulin like growth factor I receptor ... R, Brewster SF, Macaulay VM title Expression of the type 1 insulin like growth factor receptor is up ..., Bell RH, Hurtado Coll A, Fazli L, Gleave ME, Cox ME title Increased insulin like growth factor I receptor ... R, Hvid H, Klose P, da Costa A, Gruber AD. title Insulinreceptor is expressed in normal ... two cell surface receptors the IGF1 Receptor IGFR , and the insulinreceptor . The IGF 1 receptor seems to be the physiologic receptor it binds IGF 1 at significantly higher affinity than it binds the insulinreceptor. Like the insulinreceptor, the IGF 1 receptor is a receptor tyrosine kinase meaning ... the Insulinreceptor at approximately 0.1x the potency of insulin. Part of this signaling may be via ... binds the insulinreceptor 100 fold less well than insulin, yet that does not correlate with the actual potency of IGF1 in vivo at inducing phosphorylation of the Insulinreceptor, and hypoglycemia ... AM, Voelker MA, Sternberg H, Timiras PS title Insulin like growth factor 1 receptor immunoreactive ... of IGF 1R and the insulinreceptor IR , especially in the regions of the ATP binding site and tyrosine ... . Interactions Insulin like growth factor 1 receptor has been shown to Protein protein interaction ... with the insulin like growth factor I receptor journal Biochem. Biophys. Res. Commun. volume ... month Aug. title Localization of the insulin like growth factor I receptor binding sites for the SH2 ... ligand induced ubiquitination and stability of the insulin like growth factor I receptor journal ... more details
ref IGF2R is a multifunctional protein receptor biochemistry receptor that binds insulin like growth .... Interactions Insulin like growth factor 2 receptor has been shown to Protein protein interaction ... T, Neville Golden J, Maxwell M title Expression of insulin like growth factors I and II and their receptor ... JC, Standring DN, et al. title Insulin like growth factor II receptor as a multifunctional binding protein ... of heterozygosity on 6q at the mannose 6 phosphate insulin like growth factor II receptor locus in human ... insulin like growth factor II receptor. journal J. Biol. Chem. volume 270 issue 25 pages 14975 82 ... of insulin like growth factor II receptor in human pancreatic cancer. journal Pancreas volume ... EI, Vorum H, et al. title Mannose 6 phosphate insulin like growth factor II receptor targets ... refend External links MeshName Insulin Like Growth Factor II Receptor PDB Gallery geneid 3482 Clusters ...PBB geneid 3482 about the cation independent mannose 6 phosphate receptor the cation dependent receptor cation dependent mannose 6 phosphate receptor In the fields of biochemistry and cell biology , the insulin like growth factor 2 receptor IGF2R , also called the cation independent mannose 6 phosphate receptor CI MPR is a protein that in humans is encoded by the IGF2R gene . ref name pmid2963003 cite ... mannose 6 phosphate receptor. Cloning and sequence of the full length cDNA and expression of functional receptor in COS cells journal J. Biol. Chem. volume 263 issue 5 pages 2553 62 year 1988 month February ... A, Francke U title Chromosomal mapping of the gene for the type II insulin like growth factor receptor cation independent mannose 6 phosphate receptor in man and mouse journal Genomics volume ... domain of the mannose 6 phosphate receptor . Binding to IGF2 is mediated through one of the repeats ... a cargo selection device for mannose 6 phosphate receptor trafficking journal Cell volume 93 issue 3 ... kDa mannose 6 phosphate receptor cytoplasmic domain by 47 kDa tail interacting protein journal ... more details
PBB geneid 122042 Relaxin insulin like family peptide receptor 2 , also known as RXFP2 , is a human G protein coupled receptor . ref name entrez cite web title Entrez Gene RXFP2 relaxin insulin like family peptide receptor 2 url http www.ncbi.nlm.nih.gov sites entrez?Db gene&Cmd ShowDetailView&TermToSearch 122042 accessdate ref The PBB Summary template is automatically maintained by Protein Box Bot. See Template PBB Controls to Stop updates. PBB Summary section title summary text The receptors for glycoprotein hormones such as follicle stimulating hormone FSH see MIM 136530 and thyroid stimulating hormone TSH see MIM 188540 are G protein coupled, 7 transmembrane receptors GPCRs with large N terminal extracellular domains. Leucine rich repeat LRR containing GPCRs LGRs form a subgroup of the GPCR superfamily. supplied by OMIM ref name entrez cite web title Entrez Gene RXFP2 relaxin insulin like family peptide receptor 2 url http www.ncbi.nlm.nih.gov sites entrez?Db gene&Cmd ShowDetailView&TermToSearch 122042 accessdate ref See also Relaxin receptor References reflist External links cite ... receptor binding surface of insulin like peptide 3. journal J. Biol. Chem. volume 281 issue 38 pages ... A, Feng S, et al. title T222P mutation of the insulin like 3 hormone receptor LGR8 is associated with testicular maldescent and hinders receptor expression on the cell surface membrane. journal Am ... cite journal author Kumagai J, Hsu SY, Matsumi H, et al. title INSL3 Leydig insulin like peptide activates the LGR8 receptor important in testis descent. journal J. Biol. Chem. volume 277 ... and activates the receptor by interacting with both the ectodomain and the exoloop 2. journal ... cite journal author Ferlin A, Simonato M, Bartoloni L, et al. title The INSL3 LGR8 GREAT ligand receptor ... of novel splice variants of LGR7 and LGR8 reveals that receptor signaling is mediated by their unique ... insulin like peptide 3. journal Mol. Endocrinol. volume 21 issue 7 pages 1699 712 year 2007 pmid ... more details
PBB geneid 339403 Relaxin insulin like family peptide receptor 4 , also known as RXFP4 , is a human G protein coupled receptor . ref name entrez cite web title Entrez Gene RXFP4 relaxin insulin like family peptide receptor 4 url http www.ncbi.nlm.nih.gov sites entrez?Db gene&Cmd ShowDetailView&TermToSearch 339403 accessdate ref The PBB Summary template is automatically maintained by Protein Box Bot. See Template PBB Controls to Stop updates. PBB Summary section title summary text GPR100 is a member of the rhodopsin family of G protein coupled receptors GPRs Fredriksson et al., 2003 . supplied by OMIM ref name entrez cite web title Entrez Gene RXFP4 relaxin insulin like family peptide receptor 4 url http www.ncbi.nlm.nih.gov sites entrez?Db gene&Cmd ShowDetailView&TermToSearch 339403 accessdate ref See also Relaxin receptor References reflist External links cite web url http www.iuphar db.org GPCR ReceptorDisplayForward?receptorID 3037 title Relaxin Family Peptide Receptors RXFP4 accessdate author authorlink coauthors date format work IUPHAR Database of Receptors and Ion Channels publisher International Union of Basic and Clinical Pharmacology pages language archiveurl archivedate quote Further reading refbegin 2 PBB Further reading citations cite journal author Bathgate RA, Ivell R, Sanborn BM, et al. title Receptors for relaxin family peptides. journal Ann. N. Y. Acad. Sci. volume 1041 issue pages 61 76 year 2005 pmid 15956688 doi 10.1196 annals.1282.010 cite journal author Bathgate ... S, Haga T, et al. title Identification of G protein coupled receptor genes from the human genome ... and characterisation of GPR100 as a novel human G protein coupled bradykinin receptor. journal ... cite journal author Liu C, Chen J, Kuei C, et al. title Relaxin 3 insulin like peptide 5 chimeric peptide, a selective ligand for G protein coupled receptor GPCR 135 and GPCR142 over leucine rich repeat containing G protein coupled receptor 7. journal Mol. Pharmacol. volume 67 issue 1 pages 231 40 year ... more details
PBB geneid 51289 Relaxin insulin like family peptide receptor 3 , also known as RXFP3 , is a human G protein coupled receptor . ref name entrez cite web title Entrez Gene RXFP3 relaxin insulin like family peptide receptor 3 url http www.ncbi.nlm.nih.gov sites entrez?Db gene&Cmd ShowDetailView&TermToSearch 51289 accessdate ref The PBB Summary template is automatically maintained by Protein Box Bot. See Template PBB Controls to Stop updates. PBB Summary section title summary text See also Relaxin receptor References reflist External links cite web url http www.iuphar db.org GPCR ReceptorDisplayForward?receptorID 3024 title Relaxin Family Peptide Receptors RXFP3 accessdate author authorlink coauthors date format work IUPHAR Database of Receptors and Ion Channels publisher International Union of Basic and Clinical Pharmacology pages language archiveurl archivedate quote Further reading refbegin 2 PBB Further reading citations cite journal author Bathgate RA, Ivell R, Sanborn BM, et al. title Receptors for relaxin family peptides. journal Ann. N. Y. Acad. Sci. volume 1041 issue pages 61 76 year 2005 pmid 15956688 doi 10.1196 annals.1282.010 cite journal author Bathgate RA, Ivell R, Sanborn BM, et al. title International Union of Pharmacology LVII recommendations for the nomenclature of receptors for relaxin family peptides. journal Pharmacol. Rev. volume 58 issue 1 pages 7 31 year 2006 pmid 16507880 doi 10.1124 pr.58.1.9 cite journal author Matsumoto M, Kamohara M, Sugimoto T, et al. title The novel G protein coupled receptor SALPR shares sequence similarity with somatostatin and angiotensin ... of relaxin 3 INSL7 as an endogenous ligand for the orphan G protein coupled receptor GPCR135. journal ... cite journal author Liu C, Chen J, Kuei C, et al. title Relaxin 3 insulin like peptide 5 chimeric peptide, a selective ligand for G protein coupled receptor GPCR 135 and GPCR142 over leucine rich repeat containing G protein coupled receptor 7. journal Mol. Pharmacol. volume 67 issue 1 pages ... more details
PBB geneid 59350 Relaxin insulin like family peptide receptor 1 , also known as RXFP1 , is a human G protein coupled receptor . ref name entrez cite web title Entrez Gene RXFP1 relaxin insulin like family peptide receptor 1 url http www.ncbi.nlm.nih.gov sites entrez?Db gene&Cmd ShowDetailView&TermToSearch 59350 accessdate ref The PBB Summary template is automatically maintained by Protein Box Bot. See Template PBB Controls to Stop updates. PBB Summary section title summary text See also Relaxin receptor References reflist External links cite web url http www.iuphar db.org GPCR ReceptorDisplayForward?receptorID 3022 title Relaxin Family Peptide Receptors RXFP1 accessdate author authorlink coauthors date format work IUPHAR Database of Receptors and Ion Channels publisher International Union of Basic and Clinical Pharmacology pages language archiveurl archivedate quote Further reading refbegin ... al. title H3 relaxin is a specific ligand for LGR7 and activates the receptor by interacting with both ... al. title Immunoexpression of the relaxin receptor LGR7 in breast and uterine tissues of humans and primates ... receptor in human endometrium throughout the menstrual cycle. journal Mol. Hum. Reprod. volume ..., Parry LJ, Samuel CS, et al. title Increased expression of the relaxin receptor LGR7 in human endometrium ... C, Chen J, Kuei C, et al. title Relaxin 3 insulin like peptide 5 chimeric peptide, a selective ligand for G protein coupled receptor GPCR 135 and GPCR142 over leucine rich repeat containing G protein coupled receptor 7. journal Mol. Pharmacol. volume 67 issue 1 pages 231 40 year 2005 pmid 15465925 ... leucine rich repeat containing G protein coupled receptor 7. journal Clin. Exp. Pharmacol. Physiol ... G protein coupled receptor 7. journal J. Biol. Chem. volume 280 issue 14 pages 14051 6 year 2005 ... Ligand activated relaxin receptor increases the transcription of IGFBP 1 and prolactin in human decidual ... receptor LGR7 in human endometrium during the secretory phase of the menstrual cycle. journal Ann ... more details
receptor , POU2F1 Oct1 Z box of insulin gene Z overlapping NRE and C2 ISF transcription ... to avoid receptor downregulation downregulation of insulinreceptor s in target cells, and to assist ... elevated blood glucose levels. Activation of insulinreceptor s leads to internal cellular ... that make up the insulinreceptor in cell membranes have been identified, and the structures of the interior ... receptor. This, in turn, causes an conformational change in the insulinreceptor that activates ... an insulin molecule has docked onto the receptor and effected its action, it may be released back into the extracellular ... of the insulinreceptor complex, followed by the action of insulin degrading enzyme . An insulin ...About the insulin protein uses of insulin in treating diabetes insulin therapy Distinguish inulin PBB geneid 3630 Image Suckale08 fig3 glucose insulin day.jpg 270px thumb The idealized diagram shows the fluctuation of blood sugar red and the sugar lowering hormone insulin blue in humans during the course ... rich meal is highlighted. Insulin is a hormone central to regulating carbohydrate and fat metabolism in the body. Insulin causes cells in the liver , muscle , and fat cell fat tissue to take up glucose from the blood , storing it as glycogen in the liver and muscle. Insulin stops the use of fat as an energy source by inhibiting the release of glucagon . When insulin is absent, glucose is not taken ... anabolic effects throughout the body. When control of insulin levels fails, diabetes mellitus will result. As a consequence, insulin is used medically to treat some forms of diabetes mellitus. Patients with Diabetes mellitus type 1 type 1 diabetes depend on external insulin most commonly Subcutaneous ... internally. Patients with Diabetes mellitus type 2 type 2 diabetes are often insulin resistance insulin resistant , and because of such resistance, may suffer from a relative insulin deficiency. Some patients with type 2 diabetes may eventually require insulin if other medications fail to control blood ... more details
did not alter receptor binding, but blocked the formation of insulin protein dimer dimer s and hexamers ... Axel Ullrich sequences the human insulinreceptor 1988 Novo Nordisk produces synthetic, recombinant ...refimprove date March 2010 An insulin analog is an altered form of insulin , different from any occurring in nature, but still available to the human body for performing the same action as human insulin ... of insulin can be changed to alter its ADME absorption, distribution, metabolism, and excretion characteristics. Officially, the U.S. Food and Drug Administration FDA refers to these as insulinreceptor ligands , although they are more commonly referred to as insulin analogs. These modifications have been used to create two types of insulin analogs those that are more readily absorbed from the injection site and therefore act faster than natural insulin injected subcutaneously, intended to supply the bolus level of insulin needed after a meal and those that are released slowly over a period of between 8 and 24 hours, intended to supply the basal level of insulin for the day. Insulin analog was first manufactured by Eli Lilly and Company . Animal insulin The amino acid sequence for insulin is almost the same in different mammals. Porc ine insulin has only a single amino acid variation from the human variety, and cattle bovine insulin varies by three amino acids. Both are active on the human Receptor biochemistry receptor with approximately the same strength. Prior to the introduction of biosynthetic human insulin, insulin derived from sharks was widely used in Japan. Even insulin ... reactions in a tiny number of people, as can genetically engineered human insulin. This is usually caused by the preservatives used in the insulin rather than the insulin molecule itself. Biosynthetic human insulin has largely replaced animal insulin. With the advent of high pressure liquid chromatography ... a maximum purity level of 97 , which raises questions about the claim of synthetic insulin s purity ... more details
are believed to be important for insulin sensitivity by preventing downregulation of insulinreceptor s in target cells. ref name hellman Such down regulation underlies insulin resistance, which is common in type 2 diabetes . It would therefore be advantageous to administer insulin to diabetic patients in a manner mimicking the natural oscillations. ref name hellman The insulin oscillations are generated by pulsatile release of the hormone from the pancreas . Insulin originates from beta cells ...Image Pancreas insulin oscillations.svg thumb right 250px Insulin release from pancreas is pulsatile with a period of 3 6 minutes. ref name hellman The insulin concentration in blood increases after meals and gradually returns to basal levels during 1 2 hours. However, the basal insulin level is not stable ..., Gylfe E, Grapengiesser E, Dansk H, Salehi A title Insulin oscillations clinically important rhythm. Antidiabetics should increase the pulsative component of the insulin release language Swedish journal ... synchronization both within and among the islet of Langerhans. Image Insulin oscillations.svg thumb right 250px Pulsatile insulin release from single beta cells is synchronized in islet of Langerhans as well as among all islets in the pancreas. Mechanism Pulsatile insulin secretion from individual beta ... hellman Image Insulin oscillations coordination.svg thumb left 150px Coordination of pulsatile insulin release. In addition to gap junctions, coordination is done by ATP signaling. Pulsatile insulin ... is believed to entrain pulsatile insulin release from the islets into a common pancreatic rhythm. ref name hellman Clinical significance The insulin oscillations are particularly pronounced in the portal vein delivering blood from the pancreas to the liver, which is a major insulin target. Disturbances of the insulin oscillations occur early in type 2 diabetes and may contribute to insulin resistance. Pulsatile insulin delivery to the portal vein or islet cell transplantation to the liver of diabetic ... more details
No footnotes date September 2009 Pulsatile insulin , sometimes called metabolic activation therapy , or cellular activation therapy describes in a literal sense the intravenous injection of insulin in pulses versus continuous infusions. Injection of insulin in pulses mimics the physiological secretions of insulin by the pancreas into the portal vein which then drains into the liver . In healthy, non diabetic individuals, pancreatic secretions of insulin correspond to the intake of food. The pancreas will secrete variable amounts of insulin based upon the amount of food consumed basically speaking, the more food that is consumed, the more insulin the pancreas will secrete among other factors. The majority ... insulin in comparison to continuous insulin infusion. Continuous exposure to insulin and glucagon ... level may partially explain the decreased action of steady state levels of insulin, while pulsatile hormone secretion may allow recovery of Receptor biochemistry receptor affinity and numbers for insulin. Intermittent intravenous insulin administration with peaks of insulin concentrations may enhance ... insulin in the treatment of diabetes. Dr. Aoki s work focused on the role of liver dysfunction ... hepatic glucose metabolism, inadequate insulin delivery, and insulin resistance. Continuing ... Insulin and the Liver Normally, insulin is secreted from the pancreas in pulses into the portal vein ... and maintenance of insulin dependent enzymes essential for glucose metabolism in the liver ... insulin level 200 500 U ml in the portal vein concomitant with high glucose levels which acts as a bimolecular signal . In non diabetic subjects, portal insulin concentrations are twofold to threefold ... of the insulin is removed, strongly insinuating that the liver is the principal metabolic target organ of the gastrointestinal tract and the pancreas. The insulin retained by the hepatocytes may itself be essential for the long term effects of insulin on hepatic glucose metabolism as well as growth ... more details
molecule are called insulin analog ues, technically insulinreceptor ligand s so named because they are not technically ... cell membrane insulinreceptor. 1988 Novo Nordisk produces recombinant biosynthetic human insulin ...About uses of insulin in treating diabetes the insulin protein insulin Image Suckale08 fig3 glucose insulin ... hormone insulin blue in humans during the course of a day containing three meals. In addition, the effect of a sucrose sugar rich versus a starch rich meal is highlighted. Insulin therapy is the treatment of diabetes by administration of exogenous insulin . Insulin is used medically to treat ... on external insulin most commonly Injection medicine Subcutaneous injection injected subcutaneously ... mellitus type 2 Type 2 diabetes mellitus are insulin resistance insulin resistant , have relatively low insulin production, or both certain patients with Type 2 diabetes may eventually require insulin ... of Insulin Preparations ref cite web url https secure.pharmacytimes.com lessons 200510 03.asp title Pharmacist s Guide to Insulin Preparations A Comprehensive Review author Takiya, Lisa, Dougherty ... Lysine Thr Threonine Ilc Isoleucine Glu Glutamine Gly Glycine Insulin is required for all animal life ... across evolutionary time. Insulin must be administered to patients who experience such a deprivation. Clinically, this condition is called diabetes mellitus type 1 . The initial sources of insulin for clinical use in humans were cow , horse , pig or fish pancreases. Insulin from these sources is effective in humans as it is nearly identical to human insulin three amino acid difference in bovine insulin, one amino acid difference in porcine . Differences in suitability of beef , pork , or fish derived insulin for individual patients have historically been due to lower preparation purity resulting in allergic reactions to the presence of non insulin substances. Though purity has improved steadily ... types of allergic reactions have also been known to occur in response to synthetic human insulin ... more details
, Native American or Asian American, Pacific Islander Family history with type 2 diabetes Insulinreceptor ... seen in obesity activating Protein Kinase C isoform theta. PKC Theta inhibits InsulinReceptor ... patients, may result in a defective tyrosine kinase activity at the insulinreceptor level ...Expert subject Medicine date December 2009 Infobox Disease Name Insulin resistance Image Caption DiseasesDB ICD10 ICD9 ICDO OMIM MedlinePlus eMedicineSubj med eMedicineTopic 1173 MeshName Insulin Resistance MeshNumber C18.452.394.968.500 Insulin resistance IR is a physiological condition where the natural hormone , insulin , becomes less effective at lowering blood sugars. The resulting increase in blood ... on http high fat nutrition.blogspot.com 2007 10 physiological insulin resistance.html dietary conditions . Certain cell types such as fat and muscle cell biology cells require insulin to absorb glucose. When these cells fail to respond adequately to circulating insulin, blood glucose levels rise. The liver helps regulate glucose levels by reducing its secretion of glucose in the presence of insulin. This normal reduction in the liver s glucose production may not occur in people with insulin resistance. Citation needed date October 2010 Insulin resistance in muscle and fat cells reduces glucose uptake and so local storage of glucose as glycogen and triglycerides , respectively , whereas insulin ... glucose production and release into the blood. Insulin resistance normally refers to reduced glucose lowering effects of insulin. However, other functions of insulin can also be affected. For example, insulin resistance in adipose tissue fat cells reduces the normal effects of insulin on lipids ... plasma . Elevated blood fatty acid concentrations associated with insulin resistance and diabetes mellitus ... to elevated blood glucose levels. High plasma levels of insulin and glucose due to insulin resistance are a major component of the metabolic syndrome . If insulin resistance exists, more insulin needs ... more details
Multiple issues primarysources March 2010 unreferenced December 2009 expert March 2010 NPH insulin or Neutral ... insulin. , is an intermediate acting insulin given to help control the blood sugar level of those ... Nordisk formulated isophane porcine insulin by adding Neutral Protamine to regular insulin. This is a suspension of crystalline zinc insulin combined with the positively charged polypeptide, protamine ... insulin, and shorter than ultralente , Insulin glargine glargine or Insulin detemir detemir . History Hans Christian Hagedorn 1888 1971 and August Krogh 1874 1949 obtained the rights for insulin ... insulin could be prolonged by the addition of protamine obtained from the milt or semen of river trout. The insulin would be added to the protamine, but the solution would have to be brought to pH 7 for injection. Canada later produced bok insulin, a mixture of zinc , protamine and porcine insulin ... of protamine and insulin and marketed it in 1950 as NPH insulin. NPH insulin has the advantage that it can be mixed with an insulin that has a faster onset to complement its longer lasting action ... of premixed insulin formulations. However, numerous medical studies have suggested that NPH has one ... comparisons with Lente insulin usually found Lente provided superior glycemic control. Eventually ... insulin. Synthetic human insulin is also complexed with NPH by adding synthetic protamine. NPH is insulin it stands for Neutral Protamine Hagedorn. NPH is an intermediate acting insulin, meaning that it takes longer to work and lasts longer than normal insulin. An example of NPH insulin is Humulin N. NPH insulin is cloudy, and has an onset of 1 2 hours. Its peak is 4 10 hours and its duration is 18 24 hours. Insulin is given to diabetic patients who require regulation of their blood sugar levels. All patients with type one diabetes require insulin therapy some patients with type two diabetes may eventually require insulin. Insulin was originally derived from beef and pork. Today insulin ... more details
Image Insulin pen.JPG thumb 400 px Two types of modern, pre filled insulin syringes. An insulin pen is used to inject insulin for the treatment of diabetes . It is composed of an insulin cartridge integrated or bought separately and a dial to measure the dose, and is used with disposable Pen needles to deliver the dose. Types of pens A number of companies make insulin pens including Novo Nordisk , Aventis and Eli Lilly and Company Eli Lilly . These companies produce pens for most of their insulins, including Insulin aspart NovoLog NovoRapid , Insulin lispro Humalog , Insulin detemir Levemir and Insulin ... insulin cartridge. When the insulin cartridge is empty, the empty cartridge is disposed of and a new ... with insulin, and when the insulin cartridge or reservoir is empty, the entire unit is discarded. Most brands of insulin are now available for use in pens, these include NovoLog , NovoRapid and Levemir ... Use Insulin pens are used by 90 to 95 of insulin treated patients in Europe, Asia, and Scandinavia ... but growing in use in the United States. Insulin pens offer several significant advantages over insulin syringes ease of handling, accuracy, and more discreet to use. To use a pen Screw or click ... on the end of the pen to deliver the dose Count to five Remove Advantages Insulin pens have ... Less injection pain as polished and coated needles are not dulled by insertion into a vial of insulin ... syringe , two different insulins cannot be mixed by the user in an insulin pen. ref http www.paralumun.com diabetespen.htm Diabetes Insulin Pen ref On the other hand, some of the newest types of insulin ... using the traditional vial and syringe method insurance coverage for insulin pens in the United States ... Insulin Pen Users group http www.diabetes.co.uk insulin diabetes and insulin pens.html Insulin Pen Reviews See also Insulin pump Syringe Standard U 100 insulin syringes Insulin syringe Insulin port ... non commercial non spam websites containing useful information. Category Insulin therapies Category ... more details
no footnotes date March 2010 refimprove date March 2010 An insulin port functions as a medication delivery channel directly into the subcutaneous tissue the tissue layer located just beneath the skin . When applying the injection port, an insertion needle guides a soft cannula a small, flexible tube under the skin. Once applied, the insertion needle is removed and only the soft cannula remains below the skin, acting as the gateway into the subcutaneous tissue. To inject through an insulin port the needle of a syringe or insulin pen is used. It is usually used to deliver insulin through the use of an insulin pump . The needle remains above the surface of the skin, while the medication is immediately delivered through the soft cannula and into the subcutaneous tissue. References http spectrum.diabetesjournals.org cgi content abstract 21 3 197 DiabetesJournals.org See also Injection port DEFAULTSORT Insulin Port Category Catheters Category Diabetes Category Insulin therapies ... more details
More footnotes date March 2010 Image Insulin pump and infusion set.JPG thumb right 300px Insulin pump ... set shown here removed from the pump . Image Insulin pump reservoir.jpg thumb right 300px Filling an insulin pump reservoir. Left to right 1 Reservoir in sterile packaging. 2 Filling the reservoir ... right 300px Image super bolus.JPG thumb right 300px The insulin pump is a medical device used for the administration of insulin in the treatment of diabetes mellitus , also known as continuous Subcutaneous tissue subcutaneous insulin infusion therapy. The device includes the pump itself including controls, processing module, and batteries a disposable reservoir for insulin inside the pump a disposable ... system to interface the insulin reservoir to the cannula. An insulin pump is an alternative to multiple daily injections of insulin by syringe Standard U 100 insulin syringes insulin syringe or an insulin pen and allows for intensive insulin therapy when used in conjunction with blood glucose monitoring and carb counting. Setting up To use an insulin pump, the reservoir must first be filled with insulin ... with the insulin prescribed for the user usually Insulin glulisine Apidra , Insulin lispro Humalog , or Insulin ... the plunger Inserting the needle into a vial of insulin Injecting the air from the reservoir into the vial to prevent a vacuum forming in the vial as insulin is withdrawn Drawing insulin into the reservoir ... into the pump and priming the tubing pushing insulin and any air bubbles through the tubing . This is done with the pump disconnected from the body to prevent accidental insulin delivery Attaching to the infusion site and priming the cannula if a new set has been inserted . Dosing An insulin pump allows the replacement of slow acting insulin for basal needs with a continuous infusion of rapid acting insulin. The insulin pump delivers a single type of fast acting insulin in two ways ref http www.diabetes.co.uk insulinInsulin pumps.html Insulin pumps ref a Bolus medicine bolus dose ... more details
drugbox IUPAC name Recombinant human insulin image CAS number ATC prefix ATC suffix ATC supplemental ... S2 S4 S8 legal UK legal US legal status routes of administration Subcutaneous Insulin degludec is a novel ultralong acting basal insulin analogue being developed by Novo Nordisk . It is injected subcutaneously ... by current marketed long acting insulins such as Insulin glargine and Insulin detemir . ref name ... Insulin work DiabetesInControl.com accessdate 2010 11 07 ref ref name businessweek cite news url http www.businessweek.com news 2010 06 25 novo s degludec insulin as effective as lantus with fewer doses.html title Novo s Degludec Insulin as Effective as Lantus With Fewer Doses work Bloomberg Businessweek ... Studies have shown that patients taking insulin degludec needed to take significantly smaller doses of basal rate basal insulin than those taking insulin glargine, while achieving similar blood glucose levels. Insulin degludec also has the ability to be mixed with other insulins, something that cannot ... druginfo monograph?cid med&drugid 20805&drugname Insulin Glargine SubQ&monotype monograph&secid 3 title Monograph Insulin Glargine Dosage & Administration work American Society of Health System Pharmacists ... of medicine at Baylor College of Medicine in Houston, Texas , insulin degludec has a unique ability to be mixed with other insulins, thereby improving glycemic control . When commenting about the insulin ... insulin aspart . This 2 component insulin retains the ultralow risk characteristics of degludec with simultaneous ... 724316 title Novel Ultralong Acting Insulin as Effective as Insulin Glargine author Lowry, Fran work Medscape accessdate 2010 11 07 ref blockquote Insulin degludec is currently in Phase III clinical ... to head Data For Long acting Insulin Degludec Show Lower Day to day Variability Compared To Insulin ... accessdate 2010 11 07 ref Novo Nordisk hopes to begin marketing the novel insulin analog in 2013. ref ... rbssHealthcareNews work Reuters title New Novo insulin fails to knock out rival Sanofi author Hirschler ... more details
of administration Subcutaneous Insulin detemir is a long acting human insulin analogue for maintaining the basal level of insulin. Novo Nordisk markets it under the trade name Levemir . It is an insulin ... ipsecsha , A 26 Week, Randomized, Parallel, Treat to Target Trial Comparing Insulin Detemir With NPH Insulin as Add On Therapy to Oral Glucose Lowering Drugs in Insulin Na ve People With Type 2 Diabetes ... this without hypoglycemia was higher with insulin detemir than with NPH insulin 26 vs. 16 , P 0.008 . Compared with NPH insulin, the risk for all hypoglycemia with insulin detemir was reduced by 47 P 0.001 and nocturnal hypoglycemia by 55 P 0.001 . Mean weight gain was 1.2 kg with insulin detemir and 2.8 kg with NPH insulin P 0.001 , and the difference in baseline adjusted final weight was 1.58 P 0.001 . In short, it was found that insulin detemir reduced Hemoglobin A1C to target levels of 7.0 for 70 of patients, similar to human basal insulin NPH, but without the same risk of hypoglycemia and with somewhat less weight gain. Regarding weight gain compared to NPH insulin, the The Levemir ... in the effects of LEVEMIR and NPH insulin is not known, since these trials were not blinded and the protocols ... issued a public health advisory for Levemir insulin after learning that 129,000 stolen vials reappeared ... full NEJMoa075392, Addition of Biphasic, Prandial, or Basal Insulin to Oral Therapy in Type 2 ... ?p af5e2f613a0f4c6690f8fdc920f48bd6&pi 5 , Insulin analogues insulin detemir and insulin aspart versus traditional human insulins NPH insulin and regular human insulin in basal bolus therapy for patients ... Package Insert Oral hypoglycemics and insulin analogs DEFAULTSORT Insulin Detemir Category Insulin ... more details
expert date March 2010 drugbox Verifiedfields changed verifiedrevid 406469364 IUPAC name image Insulin Aspart Structural Formula.gif Structural formula of insulin aspart CAS number 116094 23 6 ATC prefix ... Insulin aspart marketed by Novo Nordisk as NovoLog NovoRapid is a fast acting insulin analogue ..., which prevents the formation of hexamers, to create a faster acting insulin. The sequence was inserted into the yeast genome, and the yeast expressed the insulin analogue, which was then harvested from a bioreactor . According to JDRF, insulin aspart was approved for marketing in the United States ... of insulin aspart are as follows Metal ion zinc 19.6 ug mL Buffer disodium hydrogen ... Isotonicity agent glycerin 16 mg mL and sodium chloride 0.58 mg mL . The pH of insulin aspart ... in 45 90 minutes, and the duration is 3 5 hours. However, as with all insulin, these numbers are based .... ref name Pharmaceutical Biotechnology ref FDA. NovoLog Insulin Aspart rDNA origin Injection ... whether or not insulin aspart or NovoLog NovoRapid should be refrigerated. Recent studies have shown that there is no difference, however insulin should not be stored in intense heat for a long period ... of the insulin, and it would no longer be as effective. A good rule of thumb is to keep the insulin at around room temperature or less. Usage Insulin aspart can be used in Insulin pump CSII pumps ... medmaster a605013.html title Aspart insulin rDNA origin injection accessdate 2007 06 08 work archiveurl ... Bot retrieved archive archivedate 2007 06 10 ref Variations on Insulin Aspart NovoLog Mix 70 30 is a product marketed by Novo Nordisk which contains 30 insulin aspart and 70 insulin aspart protamine. The insulin aspart protamine portion is a crystalline form of insulin aspart, which delays the action of the insulin, giving it a prolonged absorption profile after injection. The combination ... NovoLog Prescribing Information PDF References references Oral hypoglycemics and insulin ... more details
expert Pharmacology date March 2010 nofootnotes date March 2010 primarysources date March 2010 drugbox IUPAC name image CAS number 207748 29 6 ATC prefix A10 ATC suffix AB06 PubChem DrugBank KEGG D04540 C 258 H 384 N 64 O 78 S 6 molecular weight 5823 bioavailability protein bound metabolism elimination half life excretion pregnancy AU A B1 B2 B3 C D X pregnancy US C pregnancy category legal AU Unscheduled S2 S3 S4 S5 S6 S7 S8 S9 legal CA Schedule I, II, III, IV, V, VI, VII, VIII legal UK POM legal US Rx only legal CAN OTC & Rx legal status routes of administration Subcutaneous Insulin glulisine is a rapid acting insulin analogue that differs from human insulin in that the amino acid asparagine at position B3 is replaced by lysine and the lysine in position B29 is replaced by glutamic acid . Chemically, it is 3B lysine 29B glutamic acid human insulin, has the empirical formula C sub 258 sub H sub 384 sub N sub 64 sub O sub 78 sub S sub 6 sub and a molecular weight of 5823. It was developed by Sanofi Aventis and sold under the trade name Apidra. When injected subcutaneously, it appears in the blood earlier and at higher concentrations than human insulin. When used as a meal time insulin, the dose should be given within 15 minutes before a meal or within 20 minutes after starting a meal. External links http products.sanofi aventis.us apidra apidra.html Apidra Homepage http www.genome.jp dbget bin www bget?dr D04540 http adisonline.com drugs abstract 2009 69080 Insulin Glulisine A Review of its Use in the.6.aspx Insuline Glulisine A review of its use in the management of diabetes mellitus. Drugs 2009 69 8 Oral hypoglycemics and insulin analogs pharma stub Category Insulin therapies ... more details
drugbox IUPAC name Recombinant human insulin image CAS number 160337 95 1 ATC prefix A10 ATC suffix AE04 ... Rx only legal status routes of administration Subcutaneous Insulin glargine , marketed by Sanofi Aventis under the name Lantus , is a long acting basal insulin analogue , given once daily to help control ..., it resembles basal insulin secretion of non diabetic pancreatic beta cells. Sometimes, in type ... to make more insulin , it can offer moderate control of serum glucose levels. In the absence of endogenous insulin Type 1 diabetes, depleted diabetes mellitus type 2 type two in some cases or Latent ... acting insulin taken with food to reduce the effect of prandially derived glucose. Benefit When ... Mechanism of action pharmacodynamics Insulin glargine have substitution of glycine for asparagine at A21 and two arginines added to the carboxy terminal of B chain. This allows insulin glargine to form ... port , when a physiologic pH approximately 7.4 is achieved the increase in pH causes the insulin to come out of solution resulting in the formation of microcrystals called insulin hexamers which then dissociate into insulin monomers, the functional and physiologically active unit of insulin. This gradual ... an almost peakless profile. Usage Mixing with other insulin preparations Unlike some other longer acting insulins, Lantus must not be diluted or mixed with other insulin or solution in the same syringe. ref American Diabetes Association. 2003 . Position statement Insulin administration. Diabetes ... in Germany. The investment in the production of Lantus and insulin pen manufacturing at the location Frankfurt H chst lied at 700 Mio. . In 2008 a new manufacturing plant was established for further insulin ... confirmed the advantages of insulin glargine in the treatment of heavy hypoglycaemia compared to standard NPH insulin. Insulin glargine reduces the risk of severe nocturnal hypoglycaemia. Extensive clinical ... NEJMoa0802743 , Effects of Intensive Glucose Lowering in Type 2 Diabetes ref A comparison trial of insulin ... more details
Inhalable insulin was available from September 2006 to October 2007 in the United States as a new method of delivering insulin , a drug used in the treatment of diabetes mellitus diabetes , to the body. After the withdrawal of the only inhalable formulation, all currently available insulin formulations ... cite news author Justin Gillis title Inhaled Form of Insulin Is Approved url http pqasb.pqarchiver.com ... Jan 28 2C 2006&author Justin Gillis&desc Inhaled Form of Insulin Is Approved date January 28, 2006 ... , a powdered form of recombinant human insulin, delivered through an inhaler into the lungs where it is absorbed. Insulin has also been known to help patients with breast cancer, namely women. ref name FDAapproval cite web title FDA Approves First Ever Inhaled Insulin Combination Product for Treatment ... a longer acting basal insulin by injection. ref name BBCnews cite news title Diabetes inhaler rejected for NHS Insulin that can be inhaled rather than injected has been rejected by NHS advisers on grounds ... cost of 1,100 per person per year. ref A systematic review concluded that inhaled insulin appears to be as effective, but no better than injected short acting insulin. The additional cost is so much ... insulin in diabetes mellitus a systematic review and economic evaluation journal Health technology .... History Insulin was introduced by Banting and Best from the University of Toronto in 1921 as an injectable agent. German researchers first introduced the idea of inhalable insulin in 1924. ref name ... technologies to turn insulin into a concentrated powder with particles sized for inhalation. ref name washingtonpost This technology was developed so that the inhaled insulin can effectively reach the lung capillaries where it is absorbed. ref cite web title Inhalational Insulin Therapy url http insulin news.com inhalable insulin.asp year 2005 publisher Insulin News.com accessdate 2007 10 22 archiveurl http web.archive.org web 20070930084403 http insulin news.com inhalable insulin.asp Bot retrieved ... more details
Encyclopedia
top
